Amyotrophic lateral sclerosis

• A PHASE 1B, MULTICENTER, RANDOMIZED, PLACEBO- CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND BIOLOGICAL ACTIVITY O … Pending
  2023-504746-54-00 3 "AMYOTROPHIC LATERAL SCLEROSIS"
• Therapeutic approach of repeated transient blood-brain barrier opening in amyotrophic lateral sclerosis Pending
  2024-513471-40-00 9 "Amyotrophic lateral Sclerosis"
• Usnoflast Neuromuscular Investigation for Treatment Efficacy in ALS (UNITE-ALS) Pending
  2025-522580-15-00 4 "Amyotrophic Lateral Sclerosis (ALS)"
• A Phase 1/2 Study of the Safety and Tolerability of ICM VTx-002 in participants with ALS Pending
  2025-522697-37-00 7 "Amyotrophic Lateral Sclerosis"
• A Phase 1b/2 Study to Evaluate NB-4746 in Participants with Amyotrophic Lateral Sclerosis. Pending
  2025-523939-18-00 9 "Amyotrofic Lateral Sclerosis (ALS)"
• Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS) Recruiting
  2025-524002-16-00 5 2026-05-12 "Amyotrophic Lateral Sclerosis"
• A Study to Investigate the Safety and Effects of LTX-002 Administered in the Spinal Canal of Participants with Amyotrophic Lateral Sclerosis Recruiting
  2025-522039-33-00 7 2026-04-09 "Amyotrophic Lateral Sclerosis"
• A clinical trial to learn about the effects of VHB937 in people with amyotrophic lateral sclerosis (ALS) Recruiting
  2024-512536-29-00 4 2025-02-28 "Amyotrophic Lateral Sclerosis (ALS)"
• The clinical trial to study a new drug, AP-2. Recruiting
  2025-524480-21-00 1 2026-04-24 "ALS and related disorders like frontotemporal dementia and A"
• A Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants Recruiting
  2025-524310-28-00 3 2026-02-02 "Epilepsy, amotrophic lateral sclerosis, neuropathy"
• Multiple Ascending Dose Study of LY4256984 in Participants with Sporadic Amyotrophic Lateral Sclerosis Recruiting
  2025-521295-60-00 1 2026-01-29 "Sporadic Amyotrophic Lateral Sclerosis"
• Phase IIB Study of PHENOGENE-1A (Cromolyn) as an Adjuvant Therapy in Mild to Moderate ALS Recruiting
  2025-520688-42-00 4 2026-01-27 "Amyotrophic Lateral Sclerosis (ALS)"
• A 52-week, Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of Siplizumab in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (A … Recruiting
  2023-506174-12-00 3 2025-11-06 "Amyotrophic Lateral Sclerosis"
• Phase 1 study to evaluate [18F]ACI-19626 as a potential PET radioligand for imaging TDP-43 inclusions in the brain of patients with suspecte … Recruiting
  2024-513097-21-00 1 2024-11-20 "Alzheimer's Disease"
• A clinical trial to learn how an investigational drug (MP-101) affects on the laboratory signs of the disease when given to Amyotrophic Late … Recruiting
  2023-507195-43-00 3 2024-07-01 "Amyotrophic Lateral Sclerosis (ALS)"
• Evaluation of the efficacy and safety of Rituximab in patients with Amyotrophic Lateral Sclerosis (ALS) Recruiting
  2022-502743-35-00 4 2024-04-22 "Sporadic Amyotrophic Lateral Sclerosis"
• Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis: A multicenter, randomized placebo controlled and biological endpoints clinical … Recruiting
  2024-518888-35-00 4 2024-01-24 "amyotrophic lateral sclerosis patients"
• Clinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral Sclerosis (TCIM-ELAII) Recruiting
  2023-506215-17-00 4 2021-05-03 "Amyotrophic Lateral Sclerosis"
• Safety and exploratory efficacy of AMT-162 for adults with SOD1 ALS Recruitment ended
  2024-517244-57-00 9 2025-03-03 "Amyotrophic Lateral Sclerosis (ALS)"
• A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of … Recruitment ended
  2023-507363-20-00 1 2024-07-12 "Amyotrophic lateral sclerosis (ALS)"
• A study into the efficacy and safety of dazucorilant (CORT113176) in patients with Amyotrophic Lateral Sclerosis Recruitment ended
  2024-514082-19-00 4 2022-11-04 "Amyotrophic Lateral Sclerosis"
• A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With … Recruitment ended
  2024-512163-31-00 10 2022-01-26 "Amyotrophic Lateral Sclerosis with Fused in Sarcoma mutation"
• A Study of BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation (ATLAS) Recruitment ended
  2023-505641-12-00 5 2021-07-27 "Amyotrophic Lateral Sclerosis (ALS) associated with SOD1 gen"
• A prospective, multicenter, randomised, double-blind, placebo-controlled, parallel groups, phase 3 Trial to compare the efficacy and safety … Suspended
  2024-511244-12-01 5 "Amyotrophic Lateral Sclerosis"

Showing 1–24 of 36 trials